Finished product reference
Pediatric Grippe
Syrup · Oral · 0.67 mg/10 mg/5mL · 120 mL
- List code
- 21610
- Pharmacologic class
- Paediatric cold and influenza symptomatic combination (category of products)
What it is and how it works
This is a category of fixed-combination syrups for symptomatic relief of colds and flu in children, typically combining an analgesic-antipyretic (e.g. paracetamol) with an antihistamine (e.g. chlorphenamine) and/or a decongestant (e.g. pseudoephedrine or phenylephrine), each acting on a different symptom. They do not treat the underlying viral infection.
Indications
Short-term symptomatic relief of fever, nasal congestion, rhinorrhoea, sneezing and aches associated with common cold and influenza in children.
Contraindications
Varies with the components; generally hypersensitivity, and decongestant- or antihistamine-containing products in young children (many regulators advise against cough and cold combination products in children under 6 years), concurrent MAOI use and severe hepatic impairment for paracetamol-containing products.
Warnings and precautions
Risk of accidental paracetamol overdose if given with other paracetamol-containing medicines; check total daily dose. Sedating antihistamines and decongestants may cause drowsiness, paradoxical excitation, tachycardia or seizures in young children. Use the dosing device provided and for no longer than a few days without medical advice.
Storage and supply
Store below 25 °C, protected from light; keep out of the reach of children.
Source: reference summary prepared from the EU SmPC/EPAR, BNF and WHO Model Formulary. The approved product information in Iran governs.
Other presentations of the same active ingredient
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.